Galectin-9 in Cancer Therapy
Journal:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume:
7
Page:
130-137
Author(s):
Shintaro Fujihara, Hirohito Mori, Hideki Kobara, Kazi Rafiq, Toshiro Niki, Mitsuomi Hirashima and Tsutomu Masaki
Histone Deacetylase Inhibitors: An Attractive Strategy for Cancer Therapy
Journal:
Current Medicinal Chemistry
Volume:
20
Page:
1858-1886
Author(s):
Jiyang Li, Guangqiang Li and Wenqing Xu
Targeting of NF-kappaB Signaling Pathway, other Signaling Pathways and Epigenetics in Therapy of Multiple Myeloma
Journal:
Cardiovascular & Hematological Disorders-Drug Targets
Volume:
13
Page:
16-34
Author(s):
Ota Fuchs
Current Status and Future Perspectives of PI3K and mTOR Inhibitor as Anticancer Drugs in Breast Cancer
Journal:
Current Cancer Drug Targets
Volume:
13
Page:
175-187
Author(s):
Xiaobei Zhang, Xi-ru Li and Jin Zhang
Diverse Mechanisms of AKT Pathway Activation in Human Malignancy
Journal:
Current Cancer Drug Targets
Volume:
13
Page:
234-244
Author(s):
Mitchell Cheung and Joseph R. Testa
P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives
Journal:
Current Cancer Drug Targets
Volume:
13
Page:
326-346
Author(s):
Ziyad Binkhathlan and Afsaneh Lavasanifar
Marine Natural Products and Related Compounds as Anticancer Agents: an Overview of their Clinical Status
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
13
Page:
603-631
Author(s):
Karina Petit and Jean-Francois Biard
Protein Homeostasis as a Therapeutic Target for Diseases of Protein Conformation
Journal:
Current Topics in Medicinal Chemistry
Volume:
12
Page:
2623-2640
Author(s):
Barbara Calamini and Richard I. Morimoto
Mesenchymal Stem/Stromal Cells: A New "Cells as Drugs" Paradigm. Efficacy and Critical Aspects in Cell Therapy
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
2459-2473
Author(s):
Laura de Girolamo, Enrico Lucarelli, Giulio Alessandri, Maria Antonietta Avanzini, Maria Ester Bernardo, Ettore Biagi, Anna Teresa Brini, Giovanna D’Amico, Franca Fagioli, Ivana Ferrero, Franco Locatelli, Rita Maccario, Mario Marazzi, Ornella Parolini, Augusto Pessina and Maria Luisa Torre ; Italian Mesenchymal Stem Cell Group (GISM)
JAK Inhibitors: Pharmacology and Clinical Activity in Chronic Myeloprolipherative Neoplasms
Journal:
Current Medicinal Chemistry
Volume:
20
Page:
1147-1161
Author(s):
J. Trelinski and T. Robak